Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, 1919 W. Taylor St., Chicago, IL 60612, USA.
Department of Population Health Nursing Science, College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave, Chicago, IL 60612, USA.
Nutrients. 2023 Feb 9;15(4):875. doi: 10.3390/nu15040875.
(1) Background: Despite iron intake recommendations, over a quarter of pregnant individuals have iron deficiency. (®) enhances iron absorption in non-pregnant populations and may have positive effects in pregnancy among those with sufficient iron stores; however, no studies have evaluated the effect of ® on maternal and neonatal iron status among individuals at risk for iron deficiency anemia in pregnancy. Thus, this study aims to assess the feasibility and preliminary efficacy of daily oral ® maternal supplementation among diverse pregnant individuals. (2) Methods: In this double-blind placebo-controlled randomized supplementation feasibility study, participants were randomized to probiotic ® + prenatal vitamin with iron or placebo + prenatal vitamin with iron from 15-20 weeks of gestation through delivery. (3) Results: Of the 20 enrolled and randomized participants, 58% (7/12) from the ® group and 75% (6/8) from the placebo group were retained. Adherence to supplementation was 72% for ®/placebo and 73% for the prenatal vitamin. A slower decline in maternal hematological and iron parameters across pregnancy was observed in the ® group compared to placebo. (4) Conclusions: ® may be a tolerable therapy during pregnancy and has the potential to affect maternal and neonatal hematological and iron status.
(1) 背景:尽管有铁摄入量的建议,但仍有超过四分之一的孕妇存在缺铁现象。(®) 在非孕妇群体中提高铁的吸收率,在铁储存充足的孕妇中可能会产生积极影响;然而,尚无研究评估 ® 对处于缺铁性贫血风险中的孕妇的母婴铁状况的影响。因此,本研究旨在评估每日口服 ® 对不同孕妇的可行性和初步疗效。(2) 方法:在这项双盲安慰剂对照随机补充可行性研究中,参与者从 15-20 孕周开始,通过分娩,随机分配至益生菌 ®+含铁的产前维生素或安慰剂+含铁的产前维生素。(3) 结果:在 20 名入组并随机分组的参与者中, ® 组有 58%(7/12),安慰剂组有 75%(6/8)的参与者保留下来。 ®/安慰剂的补充依从性为 72%,产前维生素的补充依从性为 73%。与安慰剂相比, ® 组孕妇的血液学和铁参数在整个孕期的下降速度较慢。(4) 结论: ® 可能是一种在怀孕期间可耐受的治疗方法,并有潜力影响母婴的血液学和铁状况。